Expanding Access to Affordable Drugs and Medical Devices Act
Summary
What This Bill Does
Allows certain nonprofit organizations that manufacture or distribute affordable drugs or medical devices to keep section 501(c)(3) status if Treasury and HHS designate them as public interest organizations.
Who Benefits and How
Nonprofit organizations focused on affordable drugs or medical devices gain a path to tax-exempt treatment while producing or distributing products that address shortages, unmet health needs, or high costs.
Who Bears the Burden and How
Treasury and HHS must administer a new designation regime, monitor compliance, and issue guidance, while designated nonprofits must meet governance, affordability, and stockpile-access conditions.
Key Provisions
- Creates a public-interest designation that protects eligible nonprofits from losing 501(c)(3) status for manufacturing or distributing drugs or medical devices.
- Requires Treasury, in consultation with HHS, to apply eligibility, governance, affordability, shortage, and unmet-need criteria.
- Directs Treasury and HHS to issue guidance and monitor ongoing compliance.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Allows certain nonprofit organizations that manufacture or distribute affordable drugs or medical devices to keep section 501(c)(3) status if Treasury and HHS designate them as public interest organizations.
Key Policy Areas
Healthcare, Finance, Government Operations
Primary Purpose
Allows certain nonprofit organizations that manufacture or distribute affordable drugs or medical devices to keep section 501(c)(3) status if Treasury and HHS designate them as public interest organizations.
Policy Domains
Main Provisions
Identified Gains
Contextual inference, no direct clause citation- Public-interest nonprofit drug and medical device organizations
- Patients facing shortages or unaffordable products
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- Treasury and HHS designation administrators
- Designated nonprofits subject to new conditions
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
In CommitteeMs. Rosen (for herself and Mr. Curtis) introduced the following …
Read twice and referred to the Committee on Finance.
Introduced in Senate
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Public-interest nonprofit drug and medical device organizations
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the secretary"
- → Secretary of the Treasury
- "the secretary of health and human services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology